Polyethylene oxide 150mg lozenges
Requires a prescription from a doctor or prescriber
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Suspected adverse reactions reported for Polyethylene oxide
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
1 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary.
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 30 studies.
Reviews & meta-analyses: 3 · 1964–2026
Showing all 30 studies, sorted by most relevant.
Jingxian Zhang, N. Zhao, Miao Zhang, et al.
Nano Energy, 2016
Jin Zheng, Mingxue Tang, Yan‐Yan Hu
Angewandte Chemie, 2016
Zipei Wan, D. Lei, Wei Yang, et al.
Advanced Functional Materials, 2018
Yan Jin, K. Han, Yuyan Shao, et al.
Advanced Functional Materials, 2020
Pei Zhu, Chaoyi Yan, M. Dirican, et al.
Journal of Materials Chemistry, 2018
Anil Arya, A. L. Sharma
Journal of Physics D: Applied Physics, 2017
In this review, latest updates in the poly (ethylene oxide) based electrolytes are summarized. The ultimate goal of researchers globally is towards the development of free standing solid polymeric separator for energy storage devices. This single free standing solid polymeric separator may replace the liquid and separator (organic/Inorganic) used in existing efficient/smart energy technology. As an example polyethylene oxide (PEO) consist of an electron donor rich group which provides coordinating sites to the cation for migration. Owing to this exclusive structure PEO exhibits some remarkable properties such as; low glass transition temperature, excellent flexibility and ability to make complexation with various metal salts which are unattainable by another polymer host. Hence, the PEO is the most emerging candidate that have been examined or is currently under audition for application in energy storage devices. So, this review article first provides the detailed study of the PEO properties, characteristic of constituents of the polymer electrolyte and suitable approaches for the modification of polymer electrolytes. Then, the synthesization and characterizations techniques are outlined. The structures, characteristics, and performance during charge-discharge of four types of electrolyte/separators which are Liquid, Plasticized, and dispersed/intercalated electrolyte are highlighted. The suitable ion transport mechanism proposed by researchers in the different renowned group have been discussed for better understanding of the ion dynamics in such systems.
Abstract licence: CC BY
Addisu Alemayehu Assegie, Ju-Hsiang Cheng, Li-Ming Kuo, et al.
Nanoscale, 2018
Toshio Yoshihara, Hiroyuki Tadokoro, Shunsuke Murahashi
The Journal of Chemical Physics, 1964
A. Rajeh, M. Morsi, I. Elashmawi
Vacuum, 2019
Josephine Y. T. Chong, Xavier Mulet, Lynne J. Waddington, et al.
Soft Matter, 2011
Nanostructured cubic lyotropic liquid crystalline colloidal particles (Cubosomes™) are of interest for applications such as drug and biomedical imaging agent encapsulation systems. Maintaining the stability and integrity of these nanoparticles over time is essential for their storage and application. It is well known that the triblock polyethylene oxide-polypropylene oxide-polyethylene oxide (PEO-PPO-PEO) copolymer, Pluronic F127, imparts a steric barrier to aggregation of non-lamellar lyotropic liquid crystalline particles. However, few other stabilisers have been reported for these systems. Using high throughput methodologies to prepare and characterise dispersions of monoolein and phytantriol, the performance of a wide range of triblock PEO-PPO-PEO copolymers (Pluronics) was evaluated for optimal stabilisation of cubosomes. It is shown that Pluronic F108 is superior to Pluronic F127 as a stabiliser of monoolein based nanostructured particles, as it preserves the integrity of the double diamond inverse bicontinuous cubic phase internal structure of the particles, whilst maintaining colloidal stability.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.